Clinical Trials Index

Type 1 Diabetes

A Phase II, multiple dose treatment of Type 1 diabetes with hOKT3gamma-1(Ala-Ala)
Principal Investigator: Kevan Herold, Columbia University, New York, NY

Autoantigen vaccination in human Type 1 newly diagnosed diabetes mellitus
Principal Investigator: Tihamer Orban, Joslin Diabetes Center, Boston, MA

Trial Of Thymoglobulin For Treatment Of New Onset Type 1 Diabetes Mellitus
Principal Investigator: Stephen Gitleman, University of California, San Francisco, CA


Multiple Sclerosis

Treatment of multiple sclerosis with CTLA4Ig
Principal Investigator: Samia Khoury, Brigham & Women’s Hospital, Boston, MA


Atorvastatin therapy in early multiple sclerosis
Principal Investigator: Scott Zamvil, University of California, San Francisco

MRI-Controlled Phase I/II Trial for Treatment of Relapsing MS Using Peptide-Coupled PBL Tolerance
Principal Investigator: Stephen D. Miller, Northwestern University, Chicago, IL


Others

Treatment of psoriatic arthritis with hOKT3γ(Ala-Ala)
Principal Investigator: Marcus Clark, University of Chicago, Chicago, IL

Rituximab Therapy For The Induction Of Remission and Tolerance In ANCA-Associated Vasculitis
Principal Investigators: John Stone, Johns Hopkins University and Ulrich Specks, Mayo Clinic